Active safety pen needles provide a solution to drug administration
NHS England publishes report on patient safety concerns linked to insulin safety pen needles.
A recent report by the NHS England National Patient Safety team assessed the delivery of insulin with passive safety pen needles following a three-year review after a Type 1 diabetes patient's incident of developing diabetic ketoacidosis. The investigation brought to light a theme of insulin pooling during administration with passive safety pen needles, which may have contributed to insufficient insulin delivery. These situations have profound implications for patient well-being with the potential for avoidable hospital admissions.
Active safety pen needles may offer a solution due to their manually activated safety mechanism that supports a similar injection technique to conventional pen needles. Designed to provide a balance of safety and control during the injection process, supporting those who offer lifesaving care the peace of mind they deserve whilst ensuring dose accuracy for their patients.
Download the full report here.
Tested by Healthcare Professionals
Designed for our users, the Unifine® SafeControl® safety needle has been tried and tested by 106 healthcare professionals1. Here's what they thought:
- 75% agreed that it gives them the right combination of safety and control of the drug delivery during the injection process1.
- 92% agreed that they were 100% sure that the medication dose was fully delivered1.
The majority of them acknowledged that they would prefer to use Unifine® SafeControl® if given the choice1.
1. Project Saturn B (2017) Face-to-face interviews and product evaluations commissioned with an independent market research agency. Data on file.